Structured PICO summaries for doctors and healthcare professionals, covering population, intervention, comparison, outcomes, expert commentary, and references across diabetes, endocrinology, obesity, and cardiometabolic medicine.
A three-arm trial finds a non-diet, person-centred approach matches a hypocaloric diet on metabolic measures while improving mental well-being in women with obesity. PICO summary and commentary.
A four-arm trial finds combined training plus fisetin most improves adipokines and lipids in men with obesity, with exercise the main driver. PICO summary and commentary.
A crossover trial finds honey-sweetened yogurt does not change the primary inflammatory marker in postmenopausal women, with only a single secondary signal. PICO summary and commentary.
A three-year follow-up finds most people who reached diabetes remission via intermittent calorie restriction maintained it without ongoing intervention. PICO summary and commentary.
A large BMJ trial finds vitamin D before IVF raises blood levels but does not improve live birth rates in women with PCOS. PICO summary and expert commentary.
An RCT finds the weekly GLP-1 agonist PEG-Loxe produces large dose-dependent weight loss in super-obese patients with type 2 diabetes. PICO summary and expert commentary.
A feasibility study finds preliminary but non-significant physiological responses to weight stigma in women with obesity, while proving the method workable. PICO summary and commentary.
A four-arm trial finds functional training improves obesity markers in men, with spinach thylakoid supplementation adding little. PICO summary and expert commentary.
A proof-of-concept crossover study finds a fat preload does not change postprandial glucose after sleeve gastrectomy, but raises insulin. PICO summary and commentary.
An ex-vivo study finds early empagliflozin dampens NLRP3 inflammasome activity in macrophages from post-MI diabetic patients, a mechanistic signal. PICO summary and commentary.
Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.
© 2024-2026 Hormone Insight. All rights reserved.
